Turning Point Therapeutics

-$2.00 (-3.04%) Today

$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TPTX and other ETFs, options, and stocks.

About TPTX

Turning Point Therapeutics, Inc. is a clinical-stage oncology biopharmaceutical company, which engages in designing and developing next-generation therapies that target genetic drivers of cancer to improve the lives of patients. Its product pipeline include Repotrectinib, TPX-0022, TPX-0046, and TPS-O131, a next-gen ALK inhibitor.

CEO

Athena Countouriotis

Employees

142

Headquarters

San Diego, California

Founded

2013

TPTX Key Statistics

Market Cap

3.41B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

387.11K

High Today

$65.84

Low Today

$62.63

Open Price

$65.12

Volume

298.27K

52 Week High

$141.30

52 Week Low

$54.43

Analyst Ratings

100%

of 10 ratings

Buy

100%

Hold

Sell

TPTX Earnings

-$1.02

-$0.68

-$0.34

$0.00

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Estimated

— per share

Actual

Available Aug 9, After Hours